Patent · US Active

Compounds and pharmaceutical uses thereof

US11154531B2 · kind B2 · utility

1Cited by
5References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 8, 2020
Grant dateOct 26, 2021
Priority date
Expiry dateSep 8, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA23V2002/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of treating coronavirus infection, comprising administering to a subject in need thereof an effective amount of a composition, wherein the composition comprises one or more compounds of Formula (I): or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.